Tuesday, July 30, 2024
Here's a short summary of drug sales for 4 pharmaceutical companies from earnings reports in Q2 '24. Two of the firms reported this morning (July 30th) so the data is fresh.
Included in this small sample are Johnson & Johnson (ticker: JNJ), Pfizer (ticker: PFE), Abbvie (ticker: ABBV) and Merck (ticker: MRK).
Using our Excel Add in and our Disclosures query tools, we are able to extract these segments in a flash.
A few noteworthy things. Drugs that formed a significant portion of revenue in Q2 2024 are
- Merck Keytruda (45%) and Gardasil (15%)
- J&J Stelara (13%) and Darzalex (13%)
- AbbVie Humira (16%) Skyrizi (16%)
- Pfizer Elliquis (14%)
Time Series of Revenues by Firm / Drug below
